Medicare Enrolled
Dr. James Feldman, M.D.
Cardiovascular Disease · Houston, TX
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Feldman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Feldman? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Feldman
Dr. James Feldman is a cardiovascular disease in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Feldman performed 7,286 Medicare services across 4,918 unique beneficiaries.
Between the years covered by Open Payments, Dr. Feldman received a total of $24,324 from 40 pharmaceutical and/or device companies across 348 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Feldman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 7% volume in TX$ $24,324 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,286
Medicare services
Top 7% in TX for cardiovascular disease
4,918
Unique beneficiaries
$171
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~383 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test | 1,296 | $42 | $221 |
| Office visit, established patient (20-29 min) | 790 | $65 | $122 |
| Electrocardiogram (EKG), 12-lead | 693 | $11 | $80 |
| Office visit, established patient (30-39 min) | 506 | $95 | $183 |
| Echocardiogram, transthoracic | 442 | $149 | $800 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 345 | $56 | $400 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 323 | $423 | $540 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 317 | $1,941 | $7,309 |
| Nuclear medicine study of heart muscle blood flow by pet | 316 | $147 | $487 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 310 | $19 | $50 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 310 | $27 | $150 |
| Hospital follow-up visit, moderate complexity | 263 | $64 | $276 |
| EKG interpretation and report | 210 | $7 | $60 |
| Remote pacemaker monitoring, 90 days | 184 | $21 | $65 |
| Remote pacemaker/defibrillator monitoring, 90 days | 184 | $16 | $60 |
| New patient office visit (45-59 min) | 120 | $111 | $283 |
| Initial hospital admission, moderate complexity | 81 | $101 | $360 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 78 | $677 | $1,846 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 77 | $21 | $67 |
| Ultrasound of both sides of head and neck blood flow | 54 | $150 | $478 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 43 | $146 | $495 |
| Programming of dual lead pacemaker system | 40 | $32 | $116 |
| New patient office visit (30-44 min) | 38 | $65 | $186 |
| Ultrasound of leg arteries or artery grafts | 30 | $187 | $850 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 27 | $98 | $340 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 26 | $133 | $568 |
| Office visit, established patient, complex (40-54 min) | 22 | $139 | $248 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 19 | $66 | $123 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 18 | $334 | $2,800 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $85 | $460 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $14 | $240 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $2 | $240 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $10 | $132 |
| New patient office visit, complex (60-74 min) | 13 | $158 | $365 |
| Insertion of heart rhythm monitor under skin | 11 | $3,519 | $8,000 |
| Cardiac catheterization | 11 | $228 | $1,350 |
| Initial hospital admission, high complexity | 11 | $138 | $520 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $93 | $244 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.3% high complexity
33.8% medium
53.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,324
Total received (2018-2024)
Avg $3,475/year across 7 years
Top 17% in TX for cardiovascular disease
40
Companies
348
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,450 (51.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,712 (48.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$162 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,759
2023$1,568
2022$11,921
2021$1,314
2020$766
2019$3,131
2018$3,865
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GE HealthCare
$10,200
Abbott Laboratories
$2,900
Cardinal Health 200, LLC
$2,250
Boston Scientific Corporation
$2,149
Janssen Pharmaceuticals, Inc
$1,365
BOSTON SCIENTIFIC CORPORATION
$707
Novartis Pharmaceuticals Corporation
$671
Amgen Inc.
$419
ABIOMED
$358
Medtronic, Inc.
$311
PFIZER INC.
$273
E.R. Squibb & Sons, L.L.C.
$251
Medtronic Vascular, Inc.
$243
Edwards Lifesciences Corporation
$240
BIOTRONIK INC.
$198
Impulse Dynamics (USA) Inc.
$196
Astellas Pharma US Inc
$150
Amarin Pharma Inc.
$148
Novo Nordisk Inc
$131
AstraZeneca Pharmaceuticals LP
$129
Melinta Therapeutics, Inc.
$122
Merck Sharp & Dohme LLC
$113
Philips North America LLC
$112
ABBVIE INC.
$104
SANOFI-AVENTIS U.S. LLC
$100
Regeneron Healthcare Solutions, Inc.
$90
Boehringer Ingelheim Pharmaceuticals, Inc.
$72
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$70
Esperion Therapeutics, Inc.
$62
CARDIVA MEDICAL, INC.
$42
Inspire Medical Systems, Inc.
$25
Kiniksa Pharmaceuticals International, plc
$18
Kiniksa Pharmaceuticals, Ltd.
$17
Gilead Sciences, Inc.
$14
Lexicon Pharmaceuticals, Inc.
$14
CVRx, Inc.
$14
Preventice Services, LLC
$12
Eisai Inc.
$12
Kowa Pharmaceuticals America, Inc.
$11
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 63.1% of total payments
Associated products mentioned in payments ›
(BH4) IGT Devices Undivided · AMPLATZER Vascular Plug and Accs · ANGIOJET · ASSURITY · AVEIR · AVYCAZ · Arcalyst · Assurity Pacemaker · BG Mini Plus · BRILINTA · Barostim Neo System · Baxdela · Belviq · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CONFIRM RX · COYOTE · Comet · Confirm Rx · Corlanor · ELIQUIS · EMBLEM · ENTRESTO · ESSENTIO · Edarbyclor · Ensite Cardiac Mapping System · FARXIGA · GENERAL BRADY · GENERAL TACHY · GENERAL THERAPIES · GENERAL THERAPIES · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · INOGEN · INSPIRE · INVOKANA · Impella · JARDIANCE · JETSTREAM · JOT DX · LATITUDE · LEQVIO · LINQ II · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · Micra · Mitra Clip system · NEXLETOL · Optimizer · Orsiro Mission · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RESONATE · Repatha · Resolute · Reveal LINQ · SQ RX PULSE GENERATOR · STERLING · SYNERGY · VALITUDE · VERQUVO · VIGILANT · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (51%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $334 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
376
Per 100K population
7.9
County median income
$73,104
Nearest hospital
HOUSTON BEHAVIORAL HEALTHCARE HOSPITAL LLC
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Feldman is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 7% in TX), and high industry engagement (consulting-driven, top 17%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Feldman experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Feldman performed 1,296 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Feldman receive payments from pharmaceutical companies?
Yes. Dr. Feldman received a total of $24,324 from 40 companies across 348 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Feldman's costs compare to other cardiovascular diseases in Houston?
Dr. Feldman's average Medicare payment per service is $171. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Feldman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Houston
Browse cardiovascular diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
GE HealthCare Payments to Doctors
See all physicians who received payments from GE HealthCare.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Cardinal Health 200, LLC Payments to Doctors
See all physicians who received payments from Cardinal Health 200, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology